| XLS |
|
|
|
|
|
|
|
|
€ million |
Land, |
Plant and |
Other facilities, operating and office equipment |
Construction in progress and advance payments to vendors and contractors |
Total |
|
Acquisition and manufacturing cost January 1, 2011 |
2,321.9 |
2,663.9 |
845.4 |
778.9 |
6,610.1 |
|
Currency translation |
27.3 |
3.7 |
3.4 |
–0.6 |
33.8 |
|
Changes in scope of consolidation |
0.6 |
5.1 |
2.5 |
1.1 |
9.3 |
|
Additions |
32.7 |
34.3 |
42.9 |
262.0 |
371.9 |
|
Disposals |
–23.6 |
–41.2 |
–27.7 |
–1.8 |
–94.3 |
|
Transfers |
117.1 |
159.4 |
48.7 |
–310.6 |
14.6 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2011 |
2,476.0 |
2,825.2 |
915.2 |
729.0 |
6,945.4 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2011 |
–872.5 |
–1,885.5 |
–600.5 |
–10.1 |
–3,368.6 |
|
Currency translation |
–7.4 |
2.1 |
–2.6 |
– |
–7.9 |
|
Changes in scope of consolidation |
2.9 |
– |
– |
– |
2.9 |
|
Depreciation |
–94.0 |
–175.0 |
–85.8 |
– |
–354.8 |
|
Impairment losses |
–2.2 |
– |
–0.1 |
–165.1 |
–167.4 |
|
Disposals |
14.8 |
37.0 |
26.3 |
0.9 |
79.0 |
|
Transfers |
3.4 |
–20.2 |
–0.7 |
–0.1 |
–17.6 |
|
Write-ups |
0.8 |
1.4 |
0.2 |
– |
2.4 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2011 |
–954.2 |
–2,040.2 |
–663.2 |
–174.4 |
–3,832.0 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2011 |
1,521.8 |
785.0 |
252.0 |
554.6 |
3,113.4 |
|
|
|
|
|
|
|
|
Acquisition and manufacturing cost January 1, 2012 |
2,476.0 |
2,825.2 |
915.2 |
729.0 |
6,945.4 |
|
Currency translation |
–16.1 |
–16.4 |
–5.7 |
–1.4 |
–39.6 |
|
Changes in scope of consolidation |
2.9 |
3.3 |
0.1 |
– |
6.3 |
|
Additions |
8.8 |
28.3 |
33.2 |
260.0 |
330.3 |
|
Disposals |
–42.0 |
–89.8 |
–67.1 |
–0.9 |
–199.8 |
|
Transfers |
221.9 |
293.8 |
31.0 |
–557.6 |
–10.9 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2012 |
2,651.5 |
3,044.4 |
906.7 |
429.1 |
7,031.7 |
|
|
|
|
|
|
|
|
Accumulated depreciation and impairment losses January 1, 2012 |
–954.2 |
–2,040.2 |
–663.2 |
–174.4 |
–3,832.0 |
|
Currency translation |
4.0 |
12.6 |
4.8 |
– |
21.4 |
|
Changes in scope of consolidation |
– |
– |
– |
– |
– |
|
Depreciation |
–108.7 |
–199.4 |
–88.3 |
– |
–396.4 |
|
Impairment losses |
–16.0 |
–21.5 |
–4.1 |
–2.5 |
–44.1 |
|
Disposals |
26.5 |
82.7 |
64.1 |
0.1 |
173.4 |
|
Transfers |
–4.6 |
1.2 |
1.6 |
– |
–1.8 |
|
Write-ups |
1.4 |
– |
– |
– |
1.4 |
|
Reclassification to assets held for sale |
– |
– |
– |
– |
– |
|
December 31, 2012 |
–1,051.6 |
–2,164.6 |
–685.1 |
–176.8 |
–4,078.1 |
|
|
|
|
|
|
|
|
Net carrying amount as of December 31, 2012 |
1,599.9 |
879.8 |
221.6 |
252.3 |
2,953.6 |
The changes in scope of consolidation included additions amounting to € 6.3 million (2011: € 17.4 million). The additions are due to the acquisitions of CellASIC Corp. and Biochrom AG. In 2011, changes in scope of consolidation included disposals of € 5.2 million.
Impairment losses totaled € 44.1 million in fiscal 2012 (2011: € 167.4 million). Of this total, € 26.2 million was recorded as one-time items under “other operating expenses”. Of this amount, € 18.6 million was attributable to laboratory equipment and office furnishings in Corsier-sur-Vevey, Switzerland for the Merck Serono division, € 6.7 million to restructuring of the Hull site (United Kingdom) within the Consumer Health division and € 0.9 million to restructuring within Merck Millipore. A further € 17.9 million in impairments on property, plant and equipment was recorded as impairment losses under “other operating expenses”. Of this amount, € 10.3 million was attributable to the Performance Materials division, € 4.3 million to Merck Serono, and € 3.3 million to Merck Millipore.
The total amount of property, plant and equipment used as collateral was immaterial. Total government grants and subsidies in connection with investments in property, plant and equipment during the fiscal year amounted to € 12.3 million (2011: € 14.8 million).
Directly allocable borrowing costs were capitalized; the cumulative amount was immaterial. The weighted average cost of capital used by the Group was 4.1% per annum.
Property, plant and equipment also included assets that were leased. The total value of capitalized leased assets amounted to € 10.1 million (2011: € 16.5 million) and the corresponding obligations amounted to € 9.8 million (2011: € 11.8 million) (see Note [46]).
The book values of assets classified as finance leases were as follows:
| XLS |
|
|
|
|
|
€ million |
Dec. 31, 2012 |
Dec. 31, 2011 |
|
Land and buildings |
8.8 |
14.1 |
|
Vehicles |
0.9 |
1.2 |
|
Other property, plant and equipment |
0.4 |
1.2 |
|
|
10.1 |
16.5 |
back
